NASDAQ:TMCI Treace Medical Concepts Q3 2026 Earnings Date & Estimates $4.42 +0.15 (+3.51%) Closing price 04:00 PM EasternExtended Trading$4.41 -0.01 (-0.23%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Treace Medical Concepts is estimated to report Q3 2026 earnings on Friday, November 6, 2026, before market opens. The conference call is scheduled for 8:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 6, 2026TimeBefore Market OpensConference Call8:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Treace Medical Concepts in Q3 2026Treace Medical Concepts is expected to post earnings of -$0.26 per share on revenue of $47.80 million. In the same quarter a year earlier Treace Medical Concepts reported -$0.26 per share on revenue of $50.21 million. Treace Medical Concepts last reported on August 7, 2026, posting -$0.24 per share and beating the -$0.2980 consensus estimate. Treace Medical Concepts has beaten the consensus EPS estimate in 6 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.26Expected Revenue$47.80 millionPrior-Year EPS-$0.26Prior-Year Revenue$50.21 millionExpected Revenue Growth-4.8%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.24 (Beat by +$0.0580)Last Quarter Revenue$45.38 millionEPS Beat Rate6 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Treace Medical Concepts Q3 2026 Earnings FAQ When does Treace Medical Concepts report Q3 2026 earnings? Treace Medical Concepts (NASDAQ:TMCI) is estimated to report Q3 2026 earnings on Friday, November 6, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Treace Medical Concepts' Q3 2026 earnings call? Treace Medical Concepts' Q3 2026 earnings conference call is scheduled for Friday, November 6, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Treace Medical Concepts? Analysts expect Treace Medical Concepts to post earnings of -$0.26 per share for Q3 2026. How much revenue is Treace Medical Concepts expected to report? The consensus revenue estimate for Treace Medical Concepts is $47.80 million for Q3 2026. Treace Medical Concepts Earnings HeadlinesTreace Medical Wilts Ahead of Q3 FiguresOctober 23 at 3:33 PM | baystreet.caTreace to Report Third Quarter 2026 Financial Results on November 6, 2026October 23 at 7:05 AM | globenewswire.comWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run, and Vertiv before a 1900 percent run. Now he's tracking a radical light-speed technology that could make AI 100 times faster and 100 times more energy efficient. Stocks tied to it have already climbed 133 percent, 217 percent, and 320 percent.October 26 at 1:00 AM | Brownstone Research (Ad)Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?September 25, 2026 | prnewswire.comTreace Medical (TMCI) Reports Five-Year Bunion Results. Can Evidence Drive Adoption?September 22, 2026 | insidermonkey.comTreace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D(R) Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty(R) ProcedureSeptember 18, 2026 | marketscreener.comMSee More Treace Medical Concepts Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Treace Medical Concepts? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Treace Medical Concepts and other key companies, straight to your email. Email Address About Treace Medical ConceptsTreace Medical Concepts (NASDAQ:TMCI) is a medical device company focused on developing and commercializing products for the surgical treatment of bunion deformities and other conditions affecting the foot and ankle. The company’s technologies are designed to address the underlying structural causes of bunions and support more stable correction than traditional surgical approaches. Treace’s primary product is the Lapiplasty 3D Bunion Correction System, which is used by foot and ankle surgeons to correct bunions in three dimensions. Its product portfolio also includes the Adductoplasty Midfoot Correction System and related surgical instruments, implants and fixation products intended to support procedures involving the midfoot and forefoot. Founded in 2013 and based in Ponte Vedra Beach, Florida, Treace markets its products primarily through a direct commercial organization and surgeon education programs. The company’s business has centered on expanding adoption of its surgical systems in the United States while pursuing opportunities to make its technologies available in additional markets.View Treace Medical Concepts ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Anthropic's IPO Filing Reveals a Massive Opportunity for AI Infrastructure GiantsBristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own StockBuy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big CatalystsComfort Systems Earnings: AI Slowdown or More Growth Ahead?MarketBeat Week in Review – 10/19 - 10/23Amex Stock Slides on Job Cuts, But the Real Story Is MacroBloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline Upcoming Earnings Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Baker Hughes (10/27/2026)ONEOK (10/27/2026)Robinhood Markets (10/27/2026)HSBC (10/27/2026)S&P Global (10/27/2026)Visa (10/27/2026)HCA Healthcare (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
